In August, Medizone announced that Cogmedix, the Company's manufacturing partner, had obtained EPA company and establishment numbers to serve as a manufacturer for the AsepticSure System.  Cogmedix already held FDA medical device manufacturing status. 

That EPA Registration allows Cogmedix to ship AsepticSure systems to hospitals and other users in the United States. 

Today, we are pleased to announce that EPA has granted a Registration number for the AsepticSure specific hydrogen peroxide catalyst used in the system. 

The AsepticSure Oxidative Catalyst is EPA approved for use in hospitals, clinics, food industry, sporting venues, and hotels to disinfect hard, non-porous surfaces at a 1.4% concentration.

Following the Christmas holiday period, Medizone anticipates entering into a brief trial/demonstration period in a major US hospital to confirm the disinfection results previously achieved in Canada are easily repeatable. 

The Company is very optimistic that EPA approval for US market entry signals a turning point for our commercial development program as we move into 2017.